Search Results

Editorial [Hot topic: Pharmacogenetics: Current Status and Future Perspectives (Executive Editor: Henk-Jan Guchelaar)]

Author: Guchelaar, Henk-Jan

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 135-135(1)

Publisher: Bentham Science Publishers

Diagnosis of uncertain primary tumors with the Pathwork^® tissue-of-origin test

Authors: Monzon, Federico A; Dumur, Catherine I

Source: Expert Review of Molecular Diagnostics, Volume 10, Number 1, January 2010 , pp. 17-25(9)

Publisher: Expert Reviews

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care

Author: Roukos, Dimitrios H

Source: Expert Review of Molecular Diagnostics, Volume 10, Number 1, January 2010 , pp. 33-48(16)

Publisher: Expert Reviews

Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways

Author: Lackner, Mark R

Source: Expert Review of Molecular Diagnostics, Volume 10, Number 1, January 2010 , pp. 75-87(13)

Publisher: Expert Reviews

Meaningful use of pharmacogenomics in health records: semantics should be made explicit

Author: Shabo Shvo, Amnon

Source: Pharmacogenomics, Volume 11, Number 1, January 2010 , pp. 81-87(7)

Publisher: Future Medicine

Pathology practice and pharmacogenomics

Author: Trent, Ronald JA

Source: Pharmacogenomics, Volume 11, Number 1, January 2010 , pp. 105-111(7)

Publisher: Future Medicine

News & Views in ... Personalized Medicine

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 9-11(3)

Publisher: Future Medicine

Latest News & Updates from the Personalized Medicine Coalition

Author: Abrahams, Edward

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 13-13(1)

Publisher: Future Medicine

Relating biomarkers to efficacy and the efficacy curve: a review of EGFR therapies in oncology

Authors: Stroupe, Stephen D; Colpitts, Tracey L

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 19-31(13)

Publisher: Future Medicine

Molecular pathogenesis and genetics of osteoarthritis: implications for personalized medicine

Author: Valdes, Ana M

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 49-63(15)

Publisher: Future Medicine

Taking the patient's side: the ethics of pharmacogenetics

Author: Hansson, Mats G

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 75-85(11)

Publisher: Future Medicine

A novel Transformation Model© for personalized medicine laboratory systems

Authors: McKibben, Linda J; Boone, D Joe; Marchibroda, Janet; Issa, Amalia M

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 87-94(8)

Publisher: Future Medicine

Role of intellectual property in investment-backed personalized medicine

Authors: Norviel, Vern; Akhavan, Ray; Alemozafar, Ali R

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 95-102(8)

Publisher: Future Medicine

Driving personalized medicine: capturing maximum net present value and optimal return on investment

Authors: Roth, Mollie; Keeling, Peter; Smart, Dave

Source: Personalized Medicine, Volume 7, Number 1, January 2010 , pp. 103-114(12)

Publisher: Future Medicine

Temporal characteristics of botulinum neurotoxin therapy

Authors: Lebeda, Frank J; Cer, Regina Z; Stephens, Robert M; Mudunuri, Uma

Source: Expert Review of Neurotherapeutics, Volume 10, Number 1, January 2010 , pp. 93-103(11)

Publisher: Expert Reviews

Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance

Authors: Ozdemir, V.; Husereau, D.; Hyland, S.; Samper, S.; Salleh, M. Z.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 225-230(6)

Publisher: Bentham Science Publishers

Small is Beautiful: What Can Nanotechnology Do for Personalized Medicine?

Author: Marchant, G. E.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 231-237(7)

Publisher: Bentham Science Publishers

Interview with Dr. Young-Ki Paik, President of the Human Proteome Organization (HUPO): Pharmacoproteomics and the Approaching Wave of “Proteomics Diagnostics”

Authors: Paik, Y. K.; Graham, J. E.; Jones, M.; McDonald, F.; Holmes, C.; Ozdemir, V.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 243-248(6)

Publisher: Bentham Science Publishers

Dihydropyrimidine Dehydrogenase Genotyping and Phenotyping for 5- Fluorouracil Dysmetabolism: Moving Towards Personalized Chemotherapy in Patients with Cancer

Authors: Eidens, M.; Prause, S.; Weise, A.; Klemm, M.; Weber, M. M.; Pfutzner, A.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 275-283(9)

Publisher: Bentham Science Publishers

Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

Authors: Paci, D.; Ibarreta, D.

Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacog, Volume 7, Number 4, December 2009 , pp. 284-296(13)

Publisher: Bentham Science Publishers